Prothena Corp Public (PRTA) Cash from Investing Activities (QoQ) (2012 - 2025)
Prothena Corp Public (PRTA) Cash from Investing Activities (QoQ) (2012 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Prothena Corp Public |
479.08 Mn |
149.61 Mn |
- |
| Date | Value |
|---|
| Sep 30, 2025 |
88.37% |
| Jun 30, 2025 |
-104.76% |
| Mar 31, 2025 |
2.33% |
| Dec 31, 2024 |
-377.78% |
| Sep 30, 2024 |
93.71% |
| Jun 30, 2024 |
-38.83% |
| Mar 31, 2024 |
93.19% |
| Dec 31, 2023 |
-242.08% |
| Sep 30, 2023 |
42.67% |
| Jun 30, 2023 |
-1,506.25% |
| Mar 31, 2023 |
68.21% |
| Dec 31, 2022 |
-16.15% |
| Sep 30, 2022 |
19.25% |
| Jun 30, 2022 |
-631.82% |
| Mar 31, 2022 |
93.10% |
| Dec 31, 2021 |
-53.37% |
| Mar 31, 2021 |
5.88% |
| Dec 31, 2020 |
33.77% |
| Sep 30, 2020 |
-67.39% |
| Jun 30, 2020 |
-109.09% |
